Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Wynn Resorts, Limited — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Wynn Resorts, Limited trades at $74.16 (market cap $7.59B). The key difference: Wynn Resorts, Limited is the larger of the two by market cap, and Wynn Resorts, Limited pays a 1.36% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Wynn Resorts, Limited for 77 Days on average.
| INDV | WYNN | |
|---|---|---|
Market Cap | $4.03B | $7.59B |
Volume | 2,781,171 | 1,710,617 |
Sector | Health | Consumer Cyclical |
52-Week High | $41.83 | $133.09 |
52-Week Low | $24.09 | $73.73 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $4.32B | $17.83B |
Dividend Yield | — | 1.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wynn Resorts (WYNN) trades at $75.70, up 0.98% on the day, with a bearish technical outlook despite recent earnings beats. The company shows mixed fundamentals with $7.14B revenue in 2025 but declining net margins from 11.17% in 2023 to 4.58%. Recent news highlights institutional buying interest and Macau strength, though high debt levels and significant capital expenditures for new projects create financial pressure.
Wall Street maintains strong bullish sentiment with 64% buy ratings and a $130.73 consensus price target, representing 73% upside potential. Key risks include elevated debt burden ($10.5B long-term), margin compression in U.S. operations, and execution risks on UAE expansion. The stock presents a high-risk, high-reward opportunity for investors betting on Macau recovery and successful project execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
